d'Amico International Shipping Schedules Full-Year Results Presentation for Analysts and Investors
Bitget2026/11/05 11:19Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- d'Amico International Shipping will hold a board meeting March 11, 2027, to approve 2026 annual results, followed by an investor presentation.
- Shareholders will meet April 28, 2027, to approve the annual financial statements.
- The board will meet May 13, 2027, to approve first-quarter results, followed by a presentation to analysts and investors.
- A July 29, 2027, board meeting will approve first-half results, followed by a presentation to analysts and investors.
- Directors will meet November 4, 2027, to approve third-quarter results, followed by a presentation to analysts and investors.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. d'Amico International Shipping SA published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 0912-56-2026_TELEBORSA.pdf), on November 05, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
格隆汇•2026/11/09 07:01

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
智通财经•2026/11/09 06:41

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
智通财经•2026/11/09 06:41

Crypto prices
MoreBitcoin
BTC
$73,820.8
-2.56%
Ethereum
ETH
$2,084.4
-6.64%
Tether USDt
USDT
$0.9988
+0.02%
BNB
BNB
$677.68
-2.86%
USDC
USDC
$0.9998
-0.00%
XRP
XRP
$1.09
-6.58%
Solana
SOL
$85.29
-4.19%
TRON
TRX
$0.3165
-1.22%
Zcash
ZEC
$1,203.75
-4.69%
Hyperliquid
HYPE
$73.36
-5.05%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now